通过乳酸脱氢酶B(LDHB)实现代谢重编程,可赋予诱导性多能干细胞(hiPSC)来源的自然杀伤(NK)细胞对乳酸诱导功能障碍的抵抗能力,并增强其抗肿瘤活性。
Metabolic reprogramming via LDHB confers resistance to lactate-induced dysfunction and enhanced antitumor activity in hiPSC-Derived NK cells
Zhishuai Zhang, Yuchan Mai, Jun Tang, Jiaying Ning, Yanjiao Qin, Jiaming Gu, Zhaozong Cao, Jian Liu, Tiancheng Zhou, Junwei Wang, Jeane L. Pan, Jiaheng Chen, Yanling Zhu, Guangjin Pan
Journal:Stem Cell Reports
IF:5.6
DOI:10.1016/j.stemcr.2026.103048
PMID:42594863
Published:2026-08-13
research field:代谢工程癌症生物学免疫治疗干细胞研究细胞代谢自然杀伤细胞
Abstract
Natural Killer (NK) cells generally exhibit dysfunction in tumor microenvironment (TME), significantly limiting their efficacy in antitumor therapy. Tumor cells display enhanced glycolysis, leading to lactic acid (LA) secretion and accumulation in the TME. Using human-induced pluripotent stem cell (hiPSC)-derived NK cells (iNKs) as a model, we demonstrate that LA induces substantial iNK dysfunction, including reduced survival, impaired IFN-γ secretion, and diminished tumor-killing capacity due to severely compromised mitochondrial function. To overcome LA-induced dysfunction, we knocked in an expression cassette for lactate dehydrogenase B (LDHB) into hiPSCs (LDHB-hiPSCs), enabling conversion of cellular lactate to pyruvate. iNKs derived from LDHB-hiPSCs (LDHB-iNKs) largely resisted LA-induced dysfunction, exhibiting enhanced cytotoxicity and improved survival in high-LA tumor tissues. Importantly, LDHB-iNKs show superior suppression of solid tumor formation in vivo . Our study provides a novel strategy to enhance NK cell therapy against solid tumors by reshaping the metabolic pathways.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


